Annual Financial Report
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
DiaSorin | Saluggia
DiaSorin - The Diagnostic Specialist
Results | DiaSorin
Our history | DiaSorin
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it
DiaSorin
DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube
DiaSorin | Saluggia
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin S.p.A. | DiaSorin
Annual Financial Report
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
Borsa Milano volatile, cede a realizzi dopo rally recente, giu' banche, Diasorin | Reuters
DiaSorin | Saluggia
DiaSorin Inc. | LinkedIn
Simplexa® SARS-CoV-2 Variants Direct (RUO) - DiaSorin Molecular
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin concludes acquisition of Luminex for $1.8bn
Relazione_CG_Esercizio_31 12 2008_en
DiaSorin Italia S.p.A. | DiaSorin
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
DiaSorin | Saluggia
DiaSorin | Saluggia
Meet our People | DiaSorin
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
Results | DiaSorin
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
DiaSorin Inc. | LinkedIn
Azioni Diasorin: Analisi Tecnica - Borsa Italiana
Homepage - DiaSorin Molecular
Annual Financial Report
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
Results | DiaSorin
Minnesota State College Southeast - News, Events, and Updates
LIAISON® XL | DiaSorin
Homepage - DiaSorin Molecular
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
Press Release
Annual Financial Report
DiaSorin Inc. | DiaSorin
DiaSorin Said to Weigh Deal for Covid-Testing Rival Luminex - Bloomberg
Untitled
DiaSorin Molecular LLC | LinkedIn
Milan: DiaSorin on the rise - Borsa Italiana
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant
